Scott Dreyer
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Scott Dreyer is Chief Commercial Officer & Executive VP at Collegium Pharmaceutical, Inc. since 2018.
Formerly, Mr. Dreyer was Vice President-US Hospital & Oncology Sales at Merck & Co., Inc. from 1994 to 2013, Chief Marketing Officer & Vice President at Biogen, Inc. from 2014 to 2016, and Senior VP-Marketing & Commercial Operations at The Medicines Co. from 2016 to 2017.
Mr. Dreyer completed an undergraduate degree at the University of Messiah in 1994.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/03/2026 | 71.770 ( 0,22 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 10/07/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| THE MEDICINES COMPANY | Ventas & Marketing | 01/12/2017 |
| BIOGEN INC. | Ventas & Marketing | 01/09/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Messiah
University of Messiah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.